Download in electronic PDF format for $35

Search the Complete Journal Archives

Nimodipine Compounded Oral Suspension: A True Documented Medical Need

Author(s):  McElhiney Linda F

Issue:  Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Abstract:  What happens when there is an entire patient population, not just a specific patient, which cannot take a commercial product due to significant adverse effects, although the commercial product has a U.S. Food and Drug Administration-approved indication for the medical problem? What should or can be done in this situation? This article discusses this dilemma using a subarachnoid hemorrhage as an example of a true documented medical need, and discusses the option and circumstances surrounding the compounding of a nimodipine oral solution, a U.S. Food and Drug Administration–approved indication for the treatment of subarachnoid hemorrhages.

Related Keywords: Linda F. McElhiney, PharmD, RPh, MSP, FIACP, FASHP, FACA, DPLA, nimodipine, dihydropyridine calcium channel blocker, formulations, US Food and Drug Administration, FDA, DQSA, subarachnoid hemorrhage, bleeding in brain, drug safety, dosage forms, adverse effects


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Nimodipine Compounded Oral Suspension: A True Documented Medical Need McElhiney Linda F Mar/Apr 2019 106-111 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms McElhiney Linda F Sep/Oct 2013 364-368 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients McElhiney Linda F Jan/Feb 2018 30-39 Buy
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Akers Michael J Jan/Feb 2017 47-56 Buy
Nimodipine 30-mg Capsules Allen Loyd V Jr Jan/Feb 2014 65 Buy
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G May/Jun 2014 208 Buy